Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult or adolescent patients greater than (\>)16 years of age
HIV-1 infection
CD4 count less than (\<)350/cubic millimeters (mm\^3)
HIV RNA viral load \>10,000 copies per milliliter (copies/mL) while on highly active antiretroviral therapy (HAART)
Documented resistance, treatment-limiting toxicity, and/or \>=6 months' prior experience with each of 3 currently available classes of antiretroviral drugs.
You may not be if
Women who are pregnant or breastfeeding;
Patients unable to self-inject;
Active, untreated opportunistic infection.
Clareo Health | A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection
